Skip to main content
. 2020 Feb 17;7(1):e000392. doi: 10.1136/bmjresp-2018-000392

Table 1.

Patient cohort and treatment

Patient number Race Age Sex % FEV1 FEV1/FVC Treatment
1 Caucasian 76 F 79.9 80.6 500
2 Caucasian and Alaska Native/American Indian 60 M 55.5 67.6 500
3 Caucasian 63 F 37.0 63.0 Placebo
4 Caucasian 58 M 51.2 86.3 1000
5 Caucasian 77 F 38.4 63.6 Placebo
6 Caucasian 78 M 50.2 49.9 1000
7 Caucasian 67 F 57.1 64.2 2000
8 Caucasian 62 M 45.4 68.8 Placebo
9 Caucasian 72 M 48.8 52.9 2000

F, female; FEV1, forced expiratory volume in one second; FVC, forced vital capacity; M, male.